Article info
PDFClinical ethics
Ethical issues in predictive genetic testing: a public health perspective
- Correspondence to: Kimberly Fulda MPH at 3500 Camp Bowie Boulevard, Fort Worth, TX 76107, USA; kfulda{at}hsc.unt.edu
Citation
Ethical issues in predictive genetic testing: a public health perspective
Publication history
- Received August 6, 2004
- Accepted May 25, 2005
- Revised May 5, 2005
- First published February 28, 2006.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by the Journal of Medical Ethics
Other content recommended for you
- The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation
- ‘A sword of Damocles’: patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study
- Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy
- Primary prevention of neurological illness early in life
- A step forward, but still inadequate: Australian health professionals’ views on the genetics and life insurance moratorium
- Medicolegal and insurance issues regarding BRCA1 and BRCA2 gene tests in high income countries
- Co-design of patient information leaflets for germline predisposition to cancer: recommendations for clinical practice from the UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar Programme and the Association of Genetic Nurse Counsellors (AGNC)
- The complexities of predictive genetic testing
- Autosomal dominant polycystic kidney disease
- Genetic testing in motor neuron disease and frontotemporal dementia: a 5-year multicentre evaluation